Adherium Limited (ADR) is a global leader in digital health technologies, developing, manufacturing and supplying solutions specifically designed to address sub-optimal medication use in patients with chronic diseases. Their innovative products aim to improve health outcomes by tackling this widespread issue. Headquartered in Australia, Adherium operates across several continents with bases in New Zealand, the United States, and the United Kingdom, ensuring they can reach a wide range of patients and healthcare providers around the world.